Delivery Order SPE2DX22D0010-SPE2D826FAH66
Award Date 10/14/25
Potential Completion Date 10/15/25
Potential Value $3.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,583.20 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 70 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder and binge eating disorder. This competitive, firm fixed-price delivery order was awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,328.29 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 10 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The award, issued on August 15, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 18, 2025. This contract was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,398.46 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 60 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder and binge eating disorder. The contract, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, utilizes firm fixed pricing and represents a non-competitive set-aside award. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,017.50 for 100 capsules of Vyvanse 30 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder and binge eating disorder. Issued on August 6, 2025, with an ultimate completion date of August 7, 2025, this firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered...
- The Defense Logistics Agency awarded a delivery order valued at $1,634.42 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 10 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order was issued on August 26, 2025, with an ultimate completion date of August 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The...
- The Defense Logistics Agency awarded a $5,644.70 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 70 mg, a prescription medication commonly used to treat attention deficit hyperactivity disorder. The contract was competitively awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, and carries a firm fixed price structure with no set-aside designation. Performance of this delivery order is based in Conshohocken, Pennsylvania, where...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,658.76 to AmerisourceBergen Drug Corp for the supply of Vyvanse capsules (30 mg) on August 20, 2025. This firm fixed-price delivery order, which is expected to be completed by August 21, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively procured with no set-aside designation, leveraging...
- The Defense Logistics Agency awarded a delivery order valued at $3,329.49 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 70 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder and binge eating disorder. Awarded on May 20, 2025, with an ultimate completion date of May 21, 2025, this firm fixed price delivery order represents a routine pharmaceutical supply transaction executed through a competitively awarded contract with no...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,826.24 for 100 capsules of Vyvanse 70 mg, a prescription medication commonly used to treat attention deficit hyperactivity disorder. The contract utilizes firm fixed pricing with no set-aside designation and was competitively awarded on September 8, 2025, with an ultimate completion date of September 9, 2025. Performance will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $2,534.95 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 30 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder. The contract was awarded on June 24, 2025, with an ultimate completion date of June 25, 2025, under firm fixed-price terms with no set-aside designation. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is...